We are a high-performance team of talented leaders that live our mission and values. Strong leadership is vital to achieving our goals and fulfilling our mission to drive significant advancements in empathy driven, best in class technologies for treating preventable conditions in the newborn care market.
Arik has extensive experience in leading growth stage companies including Somanetics where he led expansion into PICU and NICU markets resulting in a successful exit to Covidien for $350M, turnaround of $500M Terumo Cardiovascular and US market entry of digital health startup, Adherium Ltd.
Vivek is a Cofounder of NeoLight and serves as its Executive Chairman. Prior to launching NeoLight, he has held leadership roles in organizations with 100+ employees, advised tech start-ups, and has consulted with major corporations. Vivek holds a bachelor’s degree in electrical engineering and a masters in management.
Jeffrey brings experience and expertise in marketing, product development, business development, and sales support. Throughout his career he has taken a global role leading all aspects of marketing from upstream activities including market research, clinical trial management, and product development to product launch, downstream marketing and sales support. Jeff began his career at Clinical Innovations before moving on to Neoventa Medical and then Glenveigh Medical before returning to CI and then on to NeoLight.
Mark is the Vice President, Business Development for NeoLight. Among other executive positions, he has served as CEO of Galena Biopharma (NASDAQ), Apthera, Bayhill Therapeutics and Caylx Therapeutics. Mark’s extensive experience across operational and strategic management in early stage companies led him to his new role at NeoLight. He is an adjunct faculty member at San Jose State University and currently serves as a Director of Targazyme, Inc.
Kelly has over 13 years of experience implementing and leading product management & marketing activities in Orthopaedic, Labor & Delivery, NICU, and Well Baby markets including Clinical Innovations where he reached year over year product growth of $2.9M over plan (11.5% revenue growth). Kelly has demonstrated a strong record of project leadership, team development, sales support, and customer insights through strong analytical skills, and customer development.
As NeoLight’s Clinical Director, Judy leads all efforts to ensure that NeoLight’s products pass all clinical trials. In this capacity she executes strategic partnerships with hospitals and research centers. Judy’s health care experience includes serving as the founder of Clinical Solutions and the Manager of Clinical Development for Verinata Health.
Deepak has 5+ years’ experience in medical device design and engineering during which he has designed 3 medical devices – 1 FDA cleared. He is a published author of several engineering publications and patents. At NeoLight, Deepak plays a crucial role in validating new products in R&D and translating them for production. He supports executive leadership with market analysis, product placement strategy, intellectual property strategy, clinical trial management, and technical marketing.